Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus

Author： Hogan Andrew   Gaoatswe Gadintshware   Lynch Lydia   Corrigan Michelle   Woods Conor   O’Connell Jean   O’Shea Donal  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.57, Iss.4, 2014-04, pp. : 781-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Glucagon-Like Peptide-1-Based Therapies for the Treatment of Type 2 Diabetes Mellitus

By Gallwitz Baptist  

Treatments in Endocrinology, Vol. 4, Iss. 6, 2005-01 ,pp. : 361-370

Adis International

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

By  

Current Diabetes Reviews, Vol. 12, Iss. 4, 2016-10 ,pp. : 403-413

Bentham Science Publishers

Access to resources Recommend Favorite

Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus

By Cypryk Katarzyna   Vilsbøll Tina   Nadel Iwona   Smyczynska Joanna   Holst Jens Juul   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 1, 2007-01 ,pp. : 58-62

Informa Healthcare

Access to resources Recommend Favorite

Potentiation and prolongation of the insulinotropic action of glucagon-like peptide 1 by methyl pyruvate or dimethyl ester of l-glutamic acid in a type 2 diabetes animal model

By Cancelas Jesús   Villanueva-Peñacrrillo María   Valverde Isabel   Malaisse Willy  

Endocrine Journal, Vol. 16, Iss. 2, 2001-11 ,pp. : 113-116

Humana Press, Inc

Access to resources Recommend Favorite

Glucagon-like Peptide 2

By Drucker D.J.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite